Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Preferred Shares (2011 - 2014)

Perspective Therapeutics recorded quarterly Preferred Shares of $59.0 in Q2 2014, little changed quarter-over-quarter from $59.0 in Q1 2014, and little changed year-over-year from $59.0 in Q2 2013.

Perspective Therapeutics' Preferred Shares history runs 4 years deep, the most recent figure standing at $59.0 for Q2 2014.

  • In Q2 2014, Preferred Shares changed 0.0% year-over-year to $59.0; the TTM figure through Jun 2014 stood at $59.0 (changed 0.0% YoY), while the FY2014 annual figure was $59.0, changed 0.0% from the prior year.
  • Preferred Shares came in at $59.0 for Q2 2014 at Perspective Therapeutics, roughly flat from $59.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $61.0 in Q3 2013 to a low of $59.0 in Q2 2011.
  • A 4-year average of $59.31 and a median of $59.0 in 2011 frame the typical range for Preferred Shares.
  • Across the five-year window, Preferred Shares changed 0.0% in 2012 and climbed 3.39% in 2013, its largest moves.
  • Perspective Therapeutics' Preferred Shares stood at $59.0 in 2011, then changed by 0.0% to $59.0 in 2012, then increased by 3.39% to $61.0 in 2013, then decreased by 3.28% to $59.0 in 2014.
  • According to Business Quant data, Preferred Shares over the past three periods registered $59.0, $59.0, and $61.0 for Q2 2014, Q1 2014, and Q4 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2014 59.00
Mar 31, 2014 59.00
Dec 31, 2013 61.00
Sep 30, 2013 61.00
Jun 30, 2013 59.00
Mar 31, 2013 59.00
Dec 31, 2012 59.00
Sep 30, 2012 59.00
Jun 30, 2012 59.00
Mar 31, 2012 59.00
Dec 31, 2011 59.00
Sep 30, 2011 59.00
Jun 30, 2011 59.00